Intraprocedural atrial flutter transition predicts arrhythmia-free survival after “2C3L Plus” ablation for long-standing persistent atrial fibrillation

Background: Long-standing persistent atrial fibrillation (LSPAF) remains a challenge of catheter ablation. The efficiency and optimal procedural endpoints of "2C3L plus" approach-a strategy combining pulmonary vein isolation (PVI) with linear and complex fractionated atrial electrogram (CFAEs) ablation-is unclear. Methods: radiofrequency catheter ablation between January 2020 and January 2022. All patients received a standardized "2C3L plus" strategy. The primary endpoint was freedom from any documented atrial tachyarrhythmia lasting >30 s, off antiarrhythmic drugs, at 1-year follow-up. Predictors of recurrence were analyzed using multivariable Cox regression analysis. Results: = 0.014). Conclusion: In patients with LSPAF undergoing extensive "2C3L Plus" substrate ablation, the intraprocedural organization of AF-AFL-SR, rather than AF termination itself, emerged as a powerful independent predictor of 1-year arrhythmia-free survival, suggesting its value as a more meaningful prognostic endpoint.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-04-24
DOI
https://doi.org/10.3389/fcvm.2026.1781094
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intraprocedural atrial flutter transition predicts arrhythmia-free survival after “2C3L Plus” ablation for long-standing persistent atrial fibrillation

Tong Liu, Yang Yang, Kangning Han, Deyong Long
Frontiers in Cardiovascular Medicine
Atrial Fibrillation Management and Outcomes
article

Intraprocedural atrial flutter transition predicts arrhythmia-free survival after “2C3L Plus” ablation for long-standing persistent atrial fibrillation

Tong Liu, Yang Yang, Kangning Han, Deyong Long
article en

Abstract

Background: Long-standing persistent atrial fibrillation (LSPAF) remains a challenge of catheter ablation. The efficiency and optimal procedural endpoints of "2C3L plus" approach-a strategy combining pulmonary vein isolation (PVI) with linear and complex fractionated atrial electrogram (CFAEs) ablation-is unclear. Methods: radiofrequency catheter ablation between January 2020 and January 2022. All patients received a standardized "2C3L plus" strategy. The primary endpoint was freedom from any documented atrial tachyarrhythmia lasting >30 s, off antiarrhythmic drugs, at 1-year follow-up. Predictors of recurrence were analyzed using multivariable Cox regression analysis. Results: = 0.014). Conclusion: In patients with LSPAF undergoing extensive "2C3L Plus" substrate ablation, the intraprocedural organization of AF-AFL-SR, rather than AF termination itself, emerged as a powerful independent predictor of 1-year arrhythmia-free survival, suggesting its value as a more meaningful prognostic endpoint.

Frontiers in Cardiovascular MedicineVol. 13
Capital Medical University (CN), Beijing Anzhen Hospital (CN)
Openalex Percentile: Top 18%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.